.png)
JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation | 110 |
Total Visits Per Month
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | |
|---|---|---|---|---|---|---|---|
| Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation | 0 | 3 | 3 | 0 | 0 | 2 | 1 |
File Visits
| Views | |
|---|---|
| Dzeshka_Expert opinion on drug safety_Warfarin versus dabigatran_repository.pdf | 175 |
Top country views
| Views | |
|---|---|
| United States | 46 |
| Russia | 15 |
| Sweden | 9 |
| Austria | 5 |
| Canada | 5 |
| China | 4 |
| Poland | 4 |
| Ukraine | 4 |
| France | 3 |
| India | 2 |
Top cities views
| Views | |
|---|---|
| Oakland | 11 |
| Moscow | 6 |
| Ottawa | 5 |
| Vienna | 5 |
| Andover | 4 |
| Ann Arbor | 4 |
| Ashburn | 4 |
| Menlo Park | 4 |
| Mountain View | 4 |
| Warsaw | 4 |